As a clinical neurophysiologist, my expertise is evaluating neuromuscular disorders including neuromuscular transmission disorders in adults and children. I have a clinical and diagnostic expertise in evaluating small fiber neuropathy and autonomic nervous system disorders.

Peripheral neuropathy and small fiber neuropathy with autonomic involvement in systemic disease.

Peripheral neuropathy in primary amyloidosis and myelomatosis.

Autonomic disorders in Fabry's Disease.

Autonomic disorders in Alzheimer's Disease.

Neuromuscular evaluation in children with Type I Spinal Muscular Atrophy (Clinical Trial CLMI070X2201;
An open-label multi-part first-in-human study of oral
LMI070 in infants with Type 1 spinal muscular atrophy)

From June 2015 participating in: Novartis Clinical Trial CLMI070X2201: An open-label multi-part first-in-human study of oral LMI070 in infants with Type 1 spinal muscular atrophy; Role: Neuromuscular evaluation.

Expert Nomination at European Medicines Agency